Dragonfly Therapeutics

Dragonfly Therapeutics is a clinical-stage biotech company based in Waltham, Massachusetts, United States. The company is focused on developing natural killer cell-based therapies to treat a wide range of diseases, including autoimmune disorders, oncology, fibrosis, and neurological conditions. Dragonfly has established collaborations with several major pharmaceutical companies and has a pipeline of 11 drug candidates that have been advanced to the partners.